Anthem Blue Cross Blue Shield of Colorado prior authorization, page 52

CPT code lookup

Each row is one code from the public prior authorization list. The description is the procedure or service name on that source row. This is not a coverage decision.

Prior authorization codes

Prior authorization codes
CodeDescriptionSource
0238UOncology (Lynch syndrome), genomic DNA sequence analysis of MLH1, MSH2, MSH6, PMS2, and EPCAM, including small sequence changes in exonic and intronic regions, deletions, duplColorado Prior Authorization List, Pg 123 Original policy
0239UTargeted genomic sequence analysis panel, solid organ neoplasm, cell-free DNA, analysis of 311 or more genes, interrogation for sequence variants, including substitutions, insColorado Prior Authorization List, Pg 123 Original policy
0242UTargeted genomic sequence analysis panel, solid organ neoplasm, cell-free circulating DNA analysis of 55-74 genes, interrogation for sequence variants, gene copy number amplifColorado Prior Authorization List, Pg 123 Original policy
0243UObstetrics (preeclampsia), biochemical assay of placental-growth factor, time- resolved fluorescence immunoassay, maternal serum, predictive algorithm reported as a risk scoreColorado Prior Authorization List, Pg 123 Original policy
0244UOncology (solid organ), DNA, comprehensive genomic profiling, 257 genes, interrogation for single-nucleotide variants, insertions/deletions, copy number alterations, gene rearColorado Prior Authorization List, Pg 123 Original policy
0245UOncology (thyroid), mutation analysis of 10 genes and 37 RNA fusions and expression of 4 mRNA markers using next-generation sequencing, fine needle aspirate, report includes aColorado Prior Authorization List, Pg 123 Original policy
0247UObstetrics (preterm birth), insulin-like growth factor-binding protein 4 (IBP4), sex hormone-binding globulin (SHBG), quantitative measurement by LC-MS/MS, utilizing maternalColorado Prior Authorization List, Pg 124 Original policy
0248UOncology, spheroid cell culture in 3D microenvironment, 12-drug panel, brain- or brain metastasis-response prediction for each drugColorado Prior Authorization List, Pg 124 Original policy
0249UOncology (breast), semiquantitative analysis of 32 phosphoproteins andColorado Prior Authorization List, Pg 124 Original policy
0250UOncology (solid organ neoplasm), targeted genomic sequence DNA analysiColorado Prior Authorization List, Pg 124 Original policy
0253TInsertion of anterior segment aqueous drainage device, without extraocular reservoir; internal approach, into the suprachoroidal spaceColorado Prior Authorization List, Pg 124 Original policy
0254UReproductive medicine (preimplantation genetic assessment), analysis oColorado Prior Authorization List, Pg 124 Original policy
0255UAndrology (infertility), sperm-capacitation assessment of ganglioside GM1 distribution patterns, fluorescence microscopy, fresh or frozen specimen, reported as percentage of cColorado Prior Authorization List, Pg 124 Original policy
0258UAutoimmune (psoriasis), mRNA, next-generation sequencing, gene expression profiling of 50-100 genes, skin-surface collection using adhesive patch, algorithm reported as likeliColorado Prior Authorization List, Pg 124 Original policy
0260URare diseases (constitutional/heritable disorders), identification of copy number variations, inversions, insertions, translocations, and other structural variants by opticalColorado Prior Authorization List, Pg 124 Original policy
0262UOncology (solid tumor), gene expression profiling by real-time RT-PCR of 7 gene pathways (ER, AR, PI3K, MAPK, HH, TGFB, Notch), formalin-fixed paraffin- embedded (FFPE), algoriColorado Prior Authorization List, Pg 124 Original policy
0263TIntramuscular autologous bone marrow cell therapy, with preparation of harvested cells, multiple injections, one leg, including ultrasound guidance, if performed; complete proColorado Prior Authorization List, Pg 124 Original policy
0264TIntramuscular autologous bone marrow cell therapy, with preparation of harvested cells, multiple injections, one leg, including ultrasound guidance, if performed; complete proColorado Prior Authorization List, Pg 124 Original policy
0264URare diseases (constitutional/heritable disorders), identification of copy number variations, inversions, insertions, translocations, and other structural variants by opticalColorado Prior Authorization List, Pg 124 Original policy
0265TIntramuscular autologous bone marrow cell therapy, with preparation of harvested cells, multiple injections, one leg, including ultrasound guidance, if performed; unilateral oColorado Prior Authorization List, Pg 124 Original policy
0265URare constitutional and other heritable disorders, whole genome and mitochondrial DNA sequence analysis, blood, frozen and formalin-fixed paraffin- embedded (FFPE) tissue, saliColorado Prior Authorization List, Pg 124 Original policy
0266UUnexplained constitutional or other heritable disorders or syndromes, tissue- specific gene expression by whole-transcriptome and next-generation sequencing, blood, formalin-fiColorado Prior Authorization List, Pg 124 Original policy
0267URare constitutional and other heritable disorders, identification of copy number variations, inversions, insertions, translocations, and other structural variants by optical gColorado Prior Authorization List, Pg 124 Original policy
0268UHematology (atypical hemolytic uremic syndrome [aHUS]), genomic sequence analysis of 15 genes, blood, buccal swab, or amniotic fluidColorado Prior Authorization List, Pg 124 Original policy
0269UHematology (autosomal dominant congenital thrombocytopenia), genomic sequence analysis of 14 genes, blood, buccal swab, or amniotic fluidColorado Prior Authorization List, Pg 124 Original policy
0270UHematology (congenital coagulation disorders), genomic sequence analysis of 20 genes, blood, buccal swab, or amniotic fluidColorado Prior Authorization List, Pg 124 Original policy
0271UHematology (congenital neutropenia), genomic sequence analysis of 23 genes, blood, buccal swab, or amniotic fluidColorado Prior Authorization List, Pg 124 Original policy
0272UHematology (genetic bleeding disorders), genomic sequence analysis of 51 genes, blood, buccal swab, or amniotic fluid, comprehensiveColorado Prior Authorization List, Pg 124 Original policy
0273UHematology (genetic hyperfibrinolysis, delayed bleeding), genomic sequence analysis of 8 genes (F13A1, F13B, FGA, FGB, FGG, SERPINA1, SERPINE1, SERPINF2, PLAU), blood, buccalColorado Prior Authorization List, Pg 124 Original policy
0274TPercutaneous laminotomy/laminectomy (interlaminar approach) for decompression of neural elements, (with or without ligamentous resection, discectomy, facetectomy and/or foramiColorado Prior Authorization List, Pg 124 Original policy
0274UHematology (genetic platelet disorders), genomic sequence analysis of 43 genes, blood, buccal swab, or amniotic fluidColorado Prior Authorization List, Pg 124 Original policy
0276UHematology (inherited thrombocytopenia), genomic sequence analysis of 23 genes, blood, buccal swab, or amniotic fluidColorado Prior Authorization List, Pg 125 Original policy
0277UHematology (genetic platelet function disorder), genomic sequence analysis of 31 genes, blood, buccal swab, or amniotic fluidColorado Prior Authorization List, Pg 125 Original policy
0278TTranscutaneous Electrical Modulation Pain Reprocessing (Eg, Scrambler Therapy), Each Treatment Session (Includes Placement Of Electrodes)Colorado Prior Authorization List, Pg 125 Original policy
0278UHematology (genetic thrombosis), genomic sequence analysis of 12 genes, blood, buccal swab, or amniotic fluidColorado Prior Authorization List, Pg 125 Original policy
0282TPercutaneous or open implantation of neurostimulator electrode array(s), subcutaneous (peripheral subcutaneous field stimulation), including imaging guidance, when performedColorado Prior Authorization List, Pg 125 Original policy
0283TPercutaneous or open implantation of neurostimulator electrode array(s), subcutaneous (peripheral subcutaneous field stimulation), including imaging guidance, when performedColorado Prior Authorization List, Pg 125 Original policy
0284TRevision or removal of pulse generator or electrodes, including imaging guidance, when performed, including addition of new electrodes, when performedColorado Prior Authorization List, Pg 125 Original policy
0285TElectronic analysis of implanted peripheral subcutaneous field stimulation pulse generator, with reprogramming when performedColorado Prior Authorization List, Pg 125 Original policy
0285UOncology, disease progression and response monitoring to radiation, chemotherapy, or other systematic cancer treatments, cell-free DNA, quantitative branched chain DNA amplifiColorado Prior Authorization List, Pg 125 Original policy
0286UCEP72 (centrosomal protein, 72-KDa), NUDT15 (nudix hydrolase 15) and TPMT (thiopurine S-methyltransferase) (eg, drug metabolism) gene analysis, common variantsColorado Prior Authorization List, Pg 125 Original policy
0287UOncology (thyroid), DNA and mRNA, next-generation sequencing analysis of 112 genes, fine needle aspirate or formalin-fixed paraffin-embedded (FFPE) tissue, algorithmic predictColorado Prior Authorization List, Pg 125 Original policy
0288UOncology (lung), mRNA, quantitative PCR analysis of 11 genes (BAG1, BRCA1, CDC6, CDK2AP1, ERBB3, FUT3, IL11, LCK, RND3, SH3BGR, WNT3A) and 3 reference genes (ESD, TBP, YAP1)Colorado Prior Authorization List, Pg 125 Original policy
0289UNeurology (Alzheimer disease), mRNA, gene expression profiling by RNA sequencing of 24 genes, whole blood, algorithm reported as predictive risk scoreColorado Prior Authorization List, Pg 125 Original policy
0290UPain management, mRNA, gene expression profiling by RNA sequencing of 36 genes, whole blood, algorithm reported as predictive risk scoreColorado Prior Authorization List, Pg 125 Original policy
0291UPsychiatry (mood disorders), mRNA, gene expression profiling by RNA sequencing of 144 genes, whole blood, algorithm reported as predictive risk scoreColorado Prior Authorization List, Pg 125 Original policy
0292UPsychiatry (stress disorders), mRNA, gene expression profiling by RNA sequencing of 72 genes, whole blood, algorithm reported as predictive risk scoreColorado Prior Authorization List, Pg 125 Original policy
0293UPsychiatry (suicidal ideation), mRNA, gene expression profiling by RNA sequencing of 54 genes, whole blood, algorithm reported as predictive risk scoreColorado Prior Authorization List, Pg 125 Original policy
0294ULongevity and mortality risk, mRNA, gene expression profiling by RNA sequencing of 18 genes, whole blood, algorithm reported as predictive risk scoreColorado Prior Authorization List, Pg 125 Original policy
0296UOncology (oral and/or oropharyngeal cancer), gene expression profiling by RNA sequencing at least 20 molecular features (eg, human and/or microbial mRNA), saliva, algorithm reColorado Prior Authorization List, Pg 125 Original policy

Sources

Disclaimer

The information provided on this page is for general informational purposes only and does not constitute billing, coding, or reimbursement advice. Nothing on this page should be relied upon as a substitute for clinician assessment, professional billing guidance, or as a definitive statement of any payor's billing requirements or policies.

Payor agreements, fee schedules, and billing policies vary and are subject to change. Before submitting any claims related to maternity care services, including claims affected by the 2027 CPT code revisions, please consult the applicable payor agreements, coverage policies, and billing guidelines to confirm current requirements for their specific payor contracts.

Substrate makes no representation or warranty regarding the accuracy, completeness, or timeliness of the payor-specific information presented here. Providers are solely responsible for ensuring that all claims are submitted in accordance with applicable payor requirements, and Substrate assumes no liability for claim denials, underpayments, or other adverse outcomes arising from reliance on this information.